Healthcare-associated infections surveillance report

Similar documents
Healthcare-associated infections surveillance report

Healthcare-associated Infections Annual Report December 2018

Today s Agenda: 9/30/14

Multi-Drug Resistant Organisms (MDRO)

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

About MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus.

Staph and MRSA Skin Infections Fact Sheet for Schools

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Healthcare-associated Infections Annual Report

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Living with MRSA Learning how to control the spread of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Two (II) Upon signature

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

Healthcare-associated Infections Annual Report March 2015

MRSA Outbreak in Firefighters

Source: Portland State University Population Research Center (

Summary of the latest data on antibiotic resistance in the European Union

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

This coloring book from the Texas Department of State Health Services provides education for children related to antibiotic resistance.

Advice for those affected by MRSA outside of hospital If you have MRSA this booklet provides information to help manage your day-to-day life

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Antimicrobial resistance (EARS-Net)

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

Nosocomial Antibiotic Resistant Organisms

Infection Control & Prevention

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

Advice for those affected by MRSA outside of hospital

Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe

Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus

MRSA Screening (Elective Patients)

Can you treat mrsa with amoxicillin

MRSA: How to Keep This Deadly Super Bug From Infecting You

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

running head: SUPERBUGS Humphreys 1

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

Methicillin-Resistant Staphylococcus aureus

Cleaning & Sanitising Medical range. Working in harmony with nature to protect

The Core Elements of Antibiotic Stewardship for Nursing Homes

MRSA in the United Kingdom status quo and future developments

MRSA. Patient Screening Information

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

COMMISSION OF THE EUROPEAN COMMUNITIES

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany

Antimicrobial Stewardship

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

Prevalence & Risk Factors For MRSA. For Vets

Infection Control of Emerging Diseases

Horizontal vs Vertical Infection Control Strategies

Summary Report Relating to a Pilot Program to Require Reporting of Methicillin-resistant Staphylococcus aureus

Surveillance of Multi-Drug Resistant Organisms

Antibiotic Resistance

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

MRSA Screening Programme National Targeted Rollout. MRSA Screening

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Carbapenemase-Producing Enterobacteriaceae (CPE)

Antibiotic resistance: the rise of the superbugs

MRSA. by Melissa Ochs

Annual Surveillance Summary: Methicillinresistant Staphylococcus aureus (MRSA) Infections in the Military Health System (MHS), 2017

Strategies to Prevent Methicillin-Resistant Staphylococcus aureus Transmission and Infection in Acute Care Hospitals: 2014 Update

Methicillin Resistant Staphylococcus aureus:

Rapid molecular testing to detect Staphylococcus aureus in positive blood cultures improves patient management. Martin McHugh Clinical Scientist

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Staphylococcus aureus and Health Care associated Infections

Nosocomial Antibiotic Resistant Organisms MRSA & VRE

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM


North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

What bugs are keeping YOU up at night?

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Concise Antibiogram Toolkit Background

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Clorox Germicidal Wipes & Spray. The Easy & Most Effective Way to Disinfect

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

The importance of infection control in the era of multi drug resistance

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

MDRO in LTCF: Forming Networks to Control the Problem

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Antibiotic stewardship in long term care

Success for a MRSA Reduction Program: Role of Surveillance and Testing

Optimal Use Report CADTH. Canadian Agency for Drugs and Technologies in Health. Agence canadienne des médicaments et des technologies de la santé

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?

Stratégie et action européennes

Reportable Disease Surveillance & Antibiotic Resistant Bacteria

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Doxycycline staph aureus

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Antimicrobial Stewardship

Transcription:

Healthcare-associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q4 2015/16 Summary Table Q4 2015/2016 Previous quarter (Q3 2015/16) Same quarter of previous year (Q4 2014/15) Total new MRSA cases identified 1,067 785 1,082 Number of new MRSA cases associated with the reporting facility 481 382 537 Total inpatient days 1,035,544 738,513 1,014,015 Rate of MRSA associated with the reporting facility per 10,000 inpatient days (95% CI) Highlights 4.6 (4.2-5.1) 5.2 (4.7-5.7) 5.3 (4.9-5.8) July 2016 The provincial rate of new MRSA cases associated with the reporting facility decreased compared to last quarter (Q3 2015/16), however the change was not statistically significant. The rate was lower than the same quarter of last year (Q4 2014/15) and the overall trends since Q4 2014/15 was slightly downward, although the rates did not change statistically significantly. The provincial MRSA surveillance program was established to monitor the incidence and trends of healthcareassociated MRSA (either colonization or infection) among patients who have been hospitalized in acute care facilities. MRSA stands for Methicillin-resistant Staphylococcus aureus, a type of S. aureus that has become resistant to certain antibiotics such as methicillin, penicillin, amoxicillin, etc., and is thus more difficult to treat. MRSA often lives on the skin or in the nose of healthy people without causing symptoms (this is called colonization). It can, however, cause skin and other infections. Most infections are minor, such as pimples and boils. Serious infections such as wound infections, pneumonia, or septicaemia (infections getting into the bloodstream) can result in life-threatening illness or, on rare occasions, death, if left untreated. Those with weakened immune systems and chronic illnesses are more susceptible to developing an infection. MRSA is primarily spread by skin-to-skin contact or through contact with items contaminated with the bacteria. It has been shown to spread easily in healthcare settings, therefore hospital patients, and residents in nursing homes or long-term care facilities, are at a higher risk of acquiring MRSA. In addition, MRSA has been found in community settings. Hand hygiene is the most important measure to prevent the spread of MRSA in both the healthcare setting and the community. Hospitals perform active surveillance (e.g., screening of high-risk individuals) to identify patients colonized with MRSA so that precautions can be taken to prevent transmission to other patients. The PICNet website (www.picnet.ca) has general information about MRSA prevention and control, as well as the case definition, data sources, and limitations used to generate this report. If you have questions or suspect that you have MRSA, please contact your doctor or healthcare provider.

Figure 1. Provincial rate and number of new cases of MRSA associated with the reporting facility by fiscal year and quarter, British Columbia 1 Note: vertical bars on the line represent 95% confidence interval of the rates to show an estimated range of values 1 Data were aggregated by fiscal quarter for each health authority except PHSA, which aggregated the data by calendar quarter. The time frame of each fiscal quarter varied by fiscal year and there were more days in Q4 than in Q1, Q2, and Q3 each fiscal year. Case finding strategy and application of case classification for MRSA surveillance may vary over time and by health authority. Provincial Infection Control Network of British Columbia (PICNet) Page 2 of 6

Figure 2. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter for Interior Health 2 Figure 3. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter for Fraser Health 2 Excluded certain acute care facilities from Q3 of FY 2011/2012 to Q2 of FY 2012/2013 Provincial Infection Control Network of British Columbia (PICNet) Page 3 of 6

Figure 4. Rate and number of new cases of MRSA associated with the reporting facility by, fiscal year and quarter for Vancouver Coastal Health 3 Figure 5. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter for Island Health 4 3 Includes acute care facilities of Providence Health Care (PHC) 4 Formerly known as Vancouver Island Health Authority. Excluded one acute care facility between Q1 of FY 2010/2011 to Q2 of FY 2012/2103 Provincial Infection Control Network of British Columbia (PICNet) Page 4 of 6

Figure 6. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and quarter for Northern Health 5 Figure 7. Rate and number of new cases of MRSA associated with the reporting facility, by fiscal year and calendar quarter for Provincial Health Services Authority 5 Data in 2010/2011 were not available. Provincial Infection Control Network of British Columbia (PICNet) Page 5 of 6

Provincial Infection Control Network of BC (PICNet) 1001 West Broadway, Suite 504 Vancouver, BC V6H 4B1 Tel: 604-875-4844 x 22985 Fax: 604-875-4373 Website: www.picnet.ca Email: picnet@phsa.ca Disclaimer The purpose of this report is to provide information on healthcare-associated infections identified among the patients admitted to the acute care facilities to healthcare providers, decision-makers, patients, and the public. This report may be used, in whole or in part, as the basis for infection prevention and control practices to improve the quality of healthcare services. PICNet does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information in the report; neither does it intend to provide specific medical advice. Commercial uses are prohibited without express written permission.